Nosocomial Clostridium difficile colonisation and disease

Lancet. 1990 Jul 14;336(8707):97-100. doi: 10.1016/0140-6736(90)91605-a.

Abstract

To assess the risk of acquiring Clostridium difficile diarrhoea or colitis in patients colonised with C difficile, rectal swabs taken weekly for 9 weeks from patients with long-term (at least 7 days) hospital stays on three wards were cultured for C difficile. 60 (21%) of 282 patients were culture-positive for C difficile during their hospital stay, of whom 51 were symptom-free faecal excretors. C difficile diarrhoea developed in the other 9 patients; 2 were culture-positive for C difficile and had diarrhoea at the time of first culture, and 7 had diarrhoea or pseudomembranous colitis after 1-6 previously negative weekly rectal cultures. All patients with diarrhoea were on one ward, but symptom-free, excretors were found on all wards. HindIII chromosomal restriction endonuclease analysis (REA) of the C difficile isolates revealed 18 distinct types. All isolates from the patients with diarrhoea were one of two nearly identical REA types, B or B2. 26 of the 29 total B/B2 isolates were from patients on the same ward, which points to a nosocomial outbreak. The symptom-free excretors were not at increased risk of subsequent clinical illness.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Clostridium / classification*
  • Clostridium / isolation & purification
  • Clostridium Infections / epidemiology
  • Clostridium Infections / genetics
  • Clostridium Infections / transmission*
  • Cross Infection / epidemiology
  • Cross Infection / genetics
  • Cross Infection / transmission*
  • DNA Restriction Enzymes
  • Diarrhea / epidemiology
  • Diarrhea / etiology*
  • Disease Outbreaks*
  • Enterocolitis, Pseudomembranous / epidemiology
  • Enterocolitis, Pseudomembranous / etiology*
  • Evaluation Studies as Topic
  • Humans
  • Length of Stay
  • Middle Aged
  • Minnesota / epidemiology
  • Prohibitins
  • Prospective Studies
  • Restriction Mapping
  • Risk Factors
  • Serotyping / methods
  • Time Factors

Substances

  • PHB2 protein, human
  • Prohibitins
  • DNA Restriction Enzymes